                </a></li></ul></div><p><strong>Figure 4.  <span>HIV<sub>CONSV</sub>-induced T cell responses in HLA-A*0201-transgenic mice, strain HHD.</span></strong></p><a id="article1.body1.sec3.sec4.fig1.caption1.p1" name="article1.body1.sec3.sec4.fig1.caption1.p1"></a><p>(A) Mice were immunized using the DAM regimen and the vaccine-induced responses were detected in an <em>ex vivo</em> ELISPOT assay. Results are shown as a meanÂ±SD (n = 4). For doses and timing, see <a href="#s2">Methods</a>. (B) Identified epitope peptides and their origin. (C) Killing of murine EL4 A2-K<sup>d</sup> (top) and human JK A2-K<sup>d</sup> (bottom) target cells sensitized with the shown peptides in a <sup>51</sup>Cr-release assay after a 5-day <em>in vitro</em> peptide re-stimulation. Black, grey and white bars indicated effector to target ratios of 100, 50 and 25 to 1, respectively.</p>
